1. Search Result
Search Result
Results for "

Amlodipine

" in MedChemExpress (MCE) Product Catalog:

41

Inhibitors & Agonists

2

Peptides

9

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0317
    Amlodipine
    Maximum Cited Publications
    14 Publications Verification

    Calcium Channel Cardiovascular Disease Cancer
    Amlodipine, an antianginal agent and an orally active dihydropyridine calcium channel blocker, works by blocking the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine can be used for the research of high blood pressure and cancer .
    Amlodipine
  • HY-B0317B
    Amlodipine besylate
    Maximum Cited Publications
    14 Publications Verification

    Amlodipine benzenesulfonate

    Calcium Channel Cardiovascular Disease Cancer
    Amlodipine besylate (Amlodipine benzenesulfonate), an antianginal agent and an orally active dihydropyridine calcium channel blocker, works by blocking the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine besylate can be used for the research of high blood pressure and cancer .
    Amlodipine besylate
  • HY-14744A
    Levamlodipine besylate
    2 Publications Verification

    (S)-Amlodipine besylate; LevoAmlodipine besylate

    Calcium Channel MMP Cardiovascular Disease
    Levamlodipine ((S)-Amlodipine; Levoamlodipin) besylate is an orally active L-type calcium channel blocker and MMP-9 modulator with high permeability and retention properties. Levamlodipine besylate significantly enhances plaque stability and improves lipid profiles by reducing blood pressure, decreasing systolic blood pressure variability, and inhibiting MMP-9 expression in atherosclerotic plaques. Levamlodipine besylate not only alleviates cardiac and aortic hypertrophy and prevents renal atrophy, but also produces synergistic effects in blood pressure reduction and organ protection when combined with bisoprolol (HY-129029). Levamlodipine besylate exerts no significant inhibitory effect on abdominal aortic intimal hyperplasia. When excessively accumulated in the epidermis, Levamlodipine besylate may induce changes in keratin structure, impair the skin barrier and trigger inflammation; long-term use further exacerbates skin irritation caused by local administration. Levamlodipine besylate can be used in research related to hypertension and atherosclerosis .
    Levamlodipine besylate
  • HY-B0317A
    Amlodipine maleate
    Maximum Cited Publications
    14 Publications Verification

    Calcium Channel Cardiovascular Disease Cancer
    Amlodipine maleate is a dihydropyridine calcium channel blocker, acts as an orally active antianginal agent. Amlodipine maleate blocks the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine maleate can be used for the research of high blood pressure and cancer .
    Amlodipine maleate
  • HY-14744
    Levamlodipine
    2 Publications Verification

    (S)-Amlodipine; LevoAmlodipine

    Calcium Channel MMP Cardiovascular Disease Neurological Disease
    Levamlodipine ((S)-Amlodipine; Levoamlodipin) is an orally active L-type calcium channel blocker and MMP-9 modulator with high permeability and retention properties. Levamlodipine significantly enhances plaque stability and improves lipid profiles by reducing blood pressure, decreasing systolic blood pressure variability, and inhibiting MMP-9 expression in atherosclerotic plaques. Levamlodipine not only alleviates cardiac and aortic hypertrophy and prevents renal atrophy, but also produces synergistic effects in blood pressure reduction and organ protection when combined with bisoprolol (HY-129029). Levamlodipine exerts no significant inhibitory effect on abdominal aortic intimal hyperplasia. When excessively accumulated in the epidermis, Levamlodipine may induce changes in keratin structure, impair the skin barrier and trigger inflammation; long-term use further exacerbates skin irritation caused by local administration. Levamlodipine can be used in research related to hypertension and atherosclerosis .
    Levamlodipine
  • HY-B0317D

    Calcium Channel Cardiovascular Disease Cancer
    (R)-Amlodipine is the R-Enantiomer of Amlodipine (HY-B0317)
    (R)-Amlodipine
  • HY-128696

    Amlodipine aspartate

    Drug Metabolite Calcium Channel Cardiovascular Disease
    Amlodipine aspartic acid impurity (Amlodipine aspartate) is the impurity of Amlodipine aspartic acid. Amlodipine aspartic acid is a calcium channel blocker with antihypertensive and antianginal properties. Amlodipine aspartic acid impurity can control blood pressure. Amlodipine aspartic acid impurity corrects gut dysbiosis and enhances taurine and hypotaurine metabolism. Amlodipine aspartic acid impurity can be studied in research for NAFLD and hypertension .
    Amlodipine aspartic acid impurity
  • HY-B0317AS1

    Calcium Channel Isotope-Labeled Compounds Cardiovascular Disease
    Amlodipine-d9 maleate is deuterated labeled Amlodipine maleate (HY-B0317A). Amlodipine maleate is a dihydropyridine calcium channel blocker, acts as an orally active antianginal agent. Amlodipine maleate blocks the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine maleate can be used for the research of high blood pressure and cancer .
    Amlodipine-d9 maleate
  • HY-B0317S1

    Isotope-Labeled Compounds Calcium Channel Cancer
    Amlodipine-d4 is a deuterium labeled Amlodipine (HY-B0317). Amlodipine, an antianginal agent and an orally active dihydropyridine calcium channel blocker, works by blocking the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine can be used for the research of high blood pressure and cancer .
    Amlodipine-d4
  • HY-B0317F

    Calcium Channel Infection
    Amlodipine hydrochloride is a biologically active drug used to lower blood pressure and prevent chest pain. Amlodipine hydrochloride has shown synergistic effects with antimicrobial drugs in in vitro studies, especially against carbene peptide-resistant Acinetobacter baumannii. Amlodipine hydrochloride can be used in combination with other antibiotics to enhance the inhibitory effect against resistant bacteria. The use of amlodipine hydrochloride helps reduce the dosage requirements of the drug, reduce toxic effects, and delay the emergence of drug resistance .
    Amlodipine hydrochloride
  • HY-B0317C

    Calcium Channel Cardiovascular Disease Cancer
    Amlodipine mesylate, an antianginal agent and an orally active dihydropyridine calcium channel blocker, works by blocking the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine mesylate can be used for the research of high blood pressure and cancer .
    Amlodipine mesylate
  • HY-B0317S

    Isotope-Labeled Compounds Calcium Channel Cardiovascular Disease Cancer
    Amlodipine-1,1,2,2-d4 (maleate) is the deuterium labeled Amlodipine. Amlodipine, an antianginal agent and an orally active dihydropyridine calcium channel blocker, works by blocking the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine can be used for the research of high blood pressure and cancer .
    Amlodipine-1,1,2,2-d4 maleate
  • HY-158767

    Drug Derivative Others
    Dehydro amlodipine fumarate is a derivative of Dehydro amlodipine and is one of the forced degradation products of Dehydro amlodipine during oxidation and acid degradation .
    Dehydro amlodipine fumarate
  • HY-169221

    Angiotensin Receptor Cardiovascular Disease
    Perindopril arginine is an angiotensin-converting enzyme inhibitor with hypotensive activity. Perindopril arginine is used to inhibit hypertension to lower blood pressure. Perindopril arginine, when used in combination with indapamide and amlodipine, can effectively lower blood pressure and provide better target organ protection .
    Perindopril arginine
  • HY-128696R

    Amlodipine aspartate (Standard)

    Drug Metabolite Reference Standards Calcium Channel Cardiovascular Disease
    Amlodipine aspartic acid impurity (Amlodipine aspartate) (Standard) is the analytical standard of amlodipine aspartic acid impurity. This product is intended for research and analytical applications. Amlodipine aspartic acid impurity is the impurity of Amlodipine aspartic acid. Amlodipine aspartic acid is a calcium channel blocker with antihypertensive and antianginal properties. Amlodipine aspartic acid impurity can control blood pressure. Amlodipine aspartic acid impurity corrects gut dysbiosis and enhances taurine and hypotaurine metabolism. Amlodipine aspartic acid impurity can be studied in research for NAFLD and hypertension .
    Amlodipine aspartic acid impurity (Standard)
  • HY-B0317BR

    Amlodipine benzenesulfonate (Standard)

    Reference Standards Calcium Channel Cardiovascular Disease Cancer
    Amlodipine (besylate) (Standard) is the analytical standard of Amlodipine (besylate). This product is intended for research and analytical applications. Amlodipine besylate (Amlodipine benzenesulfonate), an antianginal agent and an orally active dihydropyridine calcium channel blocker, works by blocking the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine besylate can be used for the research of high blood pressure and cancer .
    Amlodipine besylate (Standard)
  • HY-B0317BS

    Amlodipine benzenesulfonate-d4 besylate

    Isotope-Labeled Compounds Calcium Channel Cardiovascular Disease Cancer
    Amlodipine-d4 (besylate) is the deuterium labeled Amlodipine besylate. Amlodipine besylate (Amlodipine benzenesulfonate), an antianginal agent and an orally active dihydropyridine calcium channel blocker, works by blocking the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine besylate can be used for the research of high blood pressure and cancer .
    Amlodipine-d4 besylate
  • HY-B0317DR

    Drug Isomer Reference Standards Cardiovascular Disease Cancer
    (R)-Amlodipine (Standard) is the analytical standard of (R)-Amlodipine. This product is intended for research and analytical applications. (R)-Amlodipine is the R-Enantiomer of Amlodipine (HY-B0317 )
    (R)-Amlodipine (Standard)
  • HY-B0317AS

    Isotope-Labeled Compounds Calcium Channel Cardiovascular Disease Cancer
    Amlodipine-d4 (maleate) is the deuterium labeled Amlodipine maleate. Amlodipine maleate is a dihydropyridine calcium channel blocker, acts as an orally active antianginal agent. Amlodipine maleate blocks the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine maleate can be used for the research of high blood pressure and cancer .
    Amlodipine-d4 maleate
  • HY-B0317AR

    Reference Standards Calcium Channel Cardiovascular Disease Cancer
    Amlodipine (maleate) (Standard) is the analytical standard of Amlodipine (maleate). This product is intended for research and analytical applications. Amlodipine maleate is a dihydropyridine calcium channel blocker, acts as an orally active antianginal agent. Amlodipine maleate blocks the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine maleate can be used for the research of high blood pressure and cancer .
    Amlodipine maleate (Standard)
  • HY-W704938

    Calcium Channel Cardiovascular Disease
    Amlodipine metabolite is a major metabolite of the calcium channel inhibitor Amlodipine (HY-B0317).
    Amlodipine metabolite
  • HY-B0317R

    Reference Standards Calcium Channel Cardiovascular Disease Cancer
    Amlodipine (Standard) is the analytical standard of Amlodipine. This product is intended for research and analytical applications. Amlodipine, an antianginal agent and an orally active dihydropyridine calcium channel blocker, works by blocking the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine can be used for the research of high blood pressure and cancer .
    Amlodipine (Standard)
  • HY-B0317DS

    Calcium Channel Isotope-Labeled Compounds Others
    (R)-Amlodipine-d4 is the deuterium labeled (R)-Amlodipine .
    (R)-Amlodipine-d4
  • HY-158767R

    Drug Derivative Reference Standards Others
    Dehydro amlodipine (fumarate) (Standard) is the analytical standard of Dehydro amlodipine (fumarate). This product is intended for research and analytical applications. Dehydro amlodipine fumarate is a derivative of Dehydro amlodipine and is one of the forced degradation products of Dehydro amlodipine during oxidation and acid degradation .
    Dehydro amlodipine fumarate (Standard)
  • HY-129244

    (S)-Amlodipine gentisate; LevoAmlodipine gentisate

    Calcium Channel Cardiovascular Disease
    Levamlodipine gentisate ((S)-Amlodipine gentisate) is a pharmacologically active amino ester with calcium channel blocker activity. Levamlodipine gentisate is used as an antihypertensive and antianginal compound. The enantiomeric purity of levamlodipine gentisate can be determined by a fast capillary electrophoresis method. The highest resolution of levamlodipine gentisate reached 9.8, indicating its potential application in compound analysis .
    Levamlodipine gentisate
  • HY-14744B

    (S)-Amlodipine hydrochloride; LevoAmlodipine hydrochloride

    Calcium Channel MMP Cardiovascular Disease
    Levamlodipine ((S)-Amlodipine; Levoamlodipin) hydrochloride is an orally active L-type calcium channel blocker and MMP-9 modulator with high permeability and retention properties. Levamlodipine hydrochloride significantly enhances plaque stability and improves lipid profiles by reducing blood pressure, decreasing systolic blood pressure variability, and inhibiting MMP-9 expression in atherosclerotic plaques. Levamlodipine hydrochloride not only alleviates cardiac and aortic hypertrophy and prevents renal atrophy, but also produces synergistic effects in blood pressure reduction and organ protection when combined with bisoprolol (HY-129029). Levamlodipine hydrochloride exerts no significant inhibitory effect on abdominal aortic intimal hyperplasia. When excessively accumulated in the epidermis, Levamlodipine hydrochloride may induce changes in keratin structure, impair the skin barrier and trigger inflammation; long-term use further exacerbates skin irritation caused by local administration. Levamlodipine hydrochloride can be used in research related to hypertension and atherosclerosis .
    Levamlodipine hydrochloride
  • HY-14744C

    (S)-Amlodipine hydrobromide; LevoAmlodipine hydrobromide

    Calcium Channel MMP Cardiovascular Disease Others
    Levamlodipine ((S)-Amlodipine; Levoamlodipin) hydrobromide is an orally active L-type calcium channel blocker and MMP-9 modulator with high permeability and retention properties. Levamlodipine hydrobromide significantly enhances plaque stability and improves lipid profiles by reducing blood pressure, decreasing systolic blood pressure variability, and inhibiting MMP-9 expression in atherosclerotic plaques. Levamlodipine hydrobromide not only alleviates cardiac and aortic hypertrophy and prevents renal atrophy, but also produces synergistic effects in blood pressure reduction and organ protection when combined with bisoprolol (HY-129029). Levamlodipine hydrobromide exerts no significant inhibitory effect on abdominal aortic intimal hyperplasia. When excessively accumulated in the epidermis, Levamlodipine hydrobromide may induce changes in keratin structure, impair the skin barrier and trigger inflammation; long-term use further exacerbates skin irritation caused by local administration. Levamlodipine hydrobromide can be used in research related to hypertension and atherosclerosis .
    Levamlodipine hydrobromide
  • HY-103005R

    Reference Standards Melatonin Receptor Drug Metabolite Neurological Disease Endocrinology
    Amlodipine (maleate) (Standard) is the analytical standard of Amlodipine (maleate). This product is intended for research and analytical applications. Amlodipine maleate is a dihydropyridine calcium channel blocker, acts as an orally active antianginal agent. Amlodipine maleate blocks the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine maleate can be used for the research of high blood pressure and cancer .
    Ramelteon metabolite M-II (Standard)
  • HY-14744S

    (S)-Amlodipine-d4; LevoAmlodipine-d4

    Isotope-Labeled Compounds Calcium Channel MMP Others
    Levamlodipine-d4 is the deuterium labeled Levamlodipine. Levamlodipine ((S)-Amlodipine; Levoamlodipin) is an orally active L-type calcium channel blocker and MMP-9 modulator with high permeability and retention properties. Levamlodipine significantly enhances plaque stability and improves lipid profiles by reducing blood pressure, decreasing systolic blood pressure variability, and inhibiting MMP-9 expression in atherosclerotic plaques. Levamlodipine not only alleviates cardiac and aortic hypertrophy and prevents renal atrophy, but also produces synergistic effects in blood pressure reduction and organ protection when combined with bisoprolol (HY-129029). Levamlodipine exerts no significant inhibitory effect on abdominal aortic intimal hyperplasia. When excessively accumulated in the epidermis, Levamlodipine may induce changes in keratin structure, impair the skin barrier and trigger inflammation; long-term use further exacerbates skin irritation caused by local administration. Levamlodipine can be used in research related to hypertension and atherosclerosis .
    Levamlodipine-d4
  • HY-137163

    Phthaloyl Amlodipine

    Drug Intermediate Others
    Amlodipine impurity 4 (Phthaloyl Amlodipine) is an impurity of Amlodipine.
    Amlodipine impurity 4
  • HY-Z7635

    Bis(aminoethoxy) Amlodipine

    Drug Intermediate Others
    Amlodipine impurity 5 (Bis(aminoethoxy) Amlodipine) is an impurity of Amlodipine.
    Amlodipine impurity 5
  • HY-Z7879

    2-Carboxybenzoyl Amlodipine

    Drug Intermediate Others
    Amlodipine impurity 7 (2-Carboxybenzoyl amlodipine) is an impurity of Amlodipine.
    Amlodipine impurity 7
  • HY-Z6635

    Amlodipine impurity 31

    Drug Intermediate Others
    Amlodipine impurity 8 (Amlodipine impurity 31) is an impurity of Amlodipine.
    Amlodipine impurity 8
  • HY-W587660

    Drug Intermediate Others
    Amlodipine impurity 2 is an impurity of Amlodipine.
    Amlodipine impurity 2
  • HY-Z7636

    Drug Intermediate Others
    Amlodipine impurity 6 is an impurity of Amlodipine.
    Amlodipine impurity 6
  • HY-W236751

    Drug Intermediate Others
    Amlodipine impurity 1 is an impurity of Amlodipine.
    Amlodipine impurity 1
  • HY-W292468

    Drug Intermediate Others
    Amlodipine impurity 3 is an impurity of Amlodipine.
    Amlodipine impurity 3
  • HY-W713017

    Isotope-Labeled Compounds Others
    5-O-Desethyl amlodipine-d3 is the deuterium labeled 5-O-Desethyl amlodipine.
    5-O-Desethyl amlodipine-d3
  • HY-B0317H

    Calcium Channel Cardiovascular Disease Cancer
    Amlodipine orotate, an antianginal agent and an orally active dihydropyridine calcium channel blocker, works by blocking the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine orotate can be used for the research of high blood pressure and cancer .
    Amlodipine orotate
  • HY-W713018

    Desmethyl amolodipine-d5

    Isotope-Labeled Compounds Others
    3-O-Desmethyl amlodipine-d5 (Desmethyl amolodipine-d5) is the deuterium labeled 3-O-Desmethyl amlodipine.
    3-O-Desmethyl amlodipine-d5
  • HY-137163R

    Phthaloyl Amlodipine (Standard)

    Reference Standards
    Phthaloylamlodipine (Standard) is the analytical standard of Phthaloylamlodipine. This product is intended for research and analytical applications.
    Phthaloylamlodipine (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: